The biotech company, Valneva announced this month about the promising work and progress on two vaccine candidates–the mosquito borne virus, chikungunya and Lyme disease.

On today’s show I am joined by Valneva President and CEO, Thomas Lingelbach to discuss the latest on these vaccine candidates.

Outbreak News Interviews logo 400x400Related: 


All-new Echo Dot (3rd Gen) – Smart speaker with Alexa – Charcoal